✦ LIBER ✦

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker

✍ Scribed by Masahiro Hirakawa, Yasushi Sato, Hiroyuki Ohnuma…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of biweekly docetaxel and

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

A phase II study of weekly docetaxel and

✍ Li, C-P; Chen, J-S; Chen, L-T; Yen, C-J; Lee, K-D; Su, W-P; Lin, P-C; Lu, C-H; T 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Phase II study of S-1 and irinotecan com

✍ Hye J KANG; Sang H CHO; Suk J OH; Sung H YANG; Moon H LEE; Eun-Kee SONG; Hyun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB